A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 7, 2015, Pages 1291-1299

  Ge, Yu Zheng ^a   Wu, Ran ^a   Xin, Hui ^a   Zhu, Meng ^b   Lu, Tian Ze ^a   Liu, Hao ^c   Xu, Zheng ^a   Yu, Peng ^d   Zhao, You Cai ^a   Li, Ming Hao ^a   Hu, Zhi Kai ^a   Zhao, Yan ^e   Zhong, Bing ^b   Xu, Xiao ^f   Zhou, Liu Hua ^a   Xu, Lu Wei ^a   Wu, Jian Ping ^a   Li, Wen Cheng ^a   Zhu, Jia Geng ^a   Jia, Rui Peng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d NANCHANG UNIVERSITY   (China)

^e JIANGSU UNIVERSITY   (China)

^f General Hospital of Jiangsu Armed Police   (China)

Author keywords

Biomarker; Clear cell renal cell carcinoma; microRNA; Prognosis

Indexed keywords

MICRORNA; TRANSCRIPTOME;

ADULT; AGED; ANTIBODY SPECIFICITY; CARCINOMA, RENAL CELL; COHORT ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KIDNEY NEOPLASMS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MORTALITY; PROGNOSIS; SURVIVAL;

ADULT; AGED; CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MICROARRAY ANALYSIS; MICRORNAS; MIDDLE AGED; ORGAN SPECIFICITY; PROGNOSIS; SURVIVAL ANALYSIS; TRANSCRIPTOME;

EID: 84938520072     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-015-1927-0     Document Type: Article

References (42)

1. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP (2008) The impact of microRNAs on protein output. Nature 455:64–71. doi:10.1038/nature07242
2. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
3. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857–866. doi:10.1038/nrc1997
4. Cancer Genome Atlas Research N (2013) Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499:43–49. doi:10.1038/nature12222
5. Catto JW et al (2011) MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol 59:671–681. doi:10.1016/j.eururo.2011.01.044
6. Chen X et al (2014) miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes. J Cancer Res Clin Oncol 140:1295–1304. doi:10.1007/s00432-014-1690-7
7. Ferlay J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403. doi:10.1016/j.ejca.2012.12.027
8. Fritz HK, Lindgren D, Ljungberg B, Axelson H, Dahlback B (2014) The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma. Eur J Cancer 50:1758–1765. doi:10.1016/j.ejca.2014.03.281
9. Gowrishankar B et al (2014) MicroRNA expression signatures of stage, grade, and progression in clear cell RCC. Cancer Biol Ther 15:329–341. doi:10.4161/cbt.27314
10. Gulati S et al (2014) Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkers. Eur Urol. doi:10.1016/j.eururo.2014.06.053
11. Hidaka H et al (2012) Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma. Oncotarget 3:44–57
12. Hildebrandt MA et al (2010) Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 29:5724–5728. doi:10.1038/onc.2010.305
13. Iorio MV, Croce CM (2012) microRNA involvement in human cancer. Carcinogenesis 33:1126–1133. doi:10.1093/carcin/bgs140
14. Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol Oncol 6:590–610. doi:10.1016/j.molonc.2012.09.006
15. Juan D et al (2010) Identification of a microRNA panel for clear-cell kidney cancer. Urology 75:835–841. doi:10.1016/j.urology.2009.10.033
16. Kozomara A, Griffiths-Jones S (2014) miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42:D68–D73. doi:10.1093/nar/gkt1181
17. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20. doi:10.1016/j.cell.2004.12.035
18. Liu H et al (2010a) Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell renal cell carcinoma. BMC Syst Biol 4:51. doi:10.1186/1752-0509-4-51
19. Liu W et al (2010b) miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene 29:4914–4924. doi:10.1038/onc.2010.237
20. Liu N et al (2012) Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol 13:633–641. doi:10.1016/S1470-2045(12)70102-X
21. Liu C et al (2014) microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway. J Cancer Res Clin Oncol. doi:10.1007/s00432-014-1836-7
22. Ljungberg B et al (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58:398–406. doi:10.1016/j.eururo.2010.06.032
23. Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z (2006) 2004 WHO classification of the renal tumors of the adults. Eur Urol 49:798–805. doi:10.1016/j.eururo.2005.11.035
24. Lopez-Beltran A, Carrasco JC, Cheng L, Scarpelli M, Kirkali Z, Montironi R (2009) 2009 Update on the classification of renal epithelial tumors in adults. Int J Urol 16:432–443. doi:10.1111/j.1442-2042.2009.02302.x
25. Lorenzen JM, Thum T (2012) Circulating and urinary microRNAs in kidney disease. Clin J Am Soc Nephrol 7:1528–1533. doi:10.2215/CJN.01170212
26. Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, Levy R (2004) Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. New Engl J Med 350:1828–1837. doi:10.1056/NEJMoa032520
27. Maher ER (2013) Genomics and epigenomics of renal cell carcinoma. Semin Cancer Biol 23:10–17. doi:10.1016/j.semcancer.2012.06.003
28. Mlcochova H, Hezova R, Stanik M, Slaby O (2014) Urine microRNAs as potential noninvasive biomarkers in urologic cancers. Urol Oncol 32(41):e41–e49. doi:10.1016/j.urolonc.2013.04.011
29. Osanto S, Qin Y, Buermans HP, Berkers J, Lerut E, Goeman JJ, van Poppel H (2012) Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing. PloS One 7:e38298. doi:10.1371/journal.pone.0038298
30. Park I et al (2014) Active surveillance for metastatic or recurrent renal cell carcinoma. J Cancer Res Clin Oncol 140:1421–1428. doi:10.1007/s00432-014-1680-9
31. Reis LO, Pereira TC, Lopes-Cendes I, Ferreira U (2010) MicroRNAs: a new paradigm on molecular urological oncology. Urology 76:521–527. doi:10.1016/j.urology.2010.03.012
32. Sandoval J, Esteller M (2012) Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 22:50–55. doi:10.1016/j.gde.2012.02.008
33. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455:58–63. doi:10.1038/nature07228
34. Shuch B et al (2014) Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol. doi:10.1016/j.eururo.2014.04.029
35. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014 CA. Cancer J Clin 64:9–29. doi:10.3322/caac.21208
36. Silva-Santos RM et al (2013) MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis. Br J Cancer 109:2646–2653. doi:10.1038/bjc.2013.552
37. White NM et al (2011) miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J Urol 186:1077–1083. doi:10.1016/j.juro.2011.04.110
38. Wu X et al (2012) Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS ONE 7:e35661. doi:10.1371/journal.pone.0035661
39. Yates LA, Norbury CJ, Gilbert RJ (2013) The long and short of microRNA. Cell 153:516–519. doi:10.1016/j.cell.2013.04.003
40. Yi Z, Fu Y, Zhao S, Zhang X, Ma C (2010) Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues. J Cancer Res Clin Oncol 136:855–862. doi:10.1007/s00432-009-0726-x
41. Yu SL et al (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13:48–57. doi:10.1016/j.ccr.2007.12.008
42. Zhao Y, Simon R (2008) BRB-ArrayTools data archive for human cancer gene expression: a unique and efficient data sharing resource. Cancer Inf 6:9–15